
95Radiotherapy dose fractionation Third edition
1. www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009
(last accessed 30/9/16)
2. Ulutin HC, Aksu G, Fayda M, Kuzhan O, Tahmaz L, Beyzadeoglu M. The value of postoperative
radiotherapy in renal cell carcinoma: a single-institution experience. Tumori 2006; 92(3): 202–206.
3. Stein M, Kuten A, Halpern J, Coachman NM, Cohen Y, Robinson E. The value of postoperative
irradiation in renal cell cancer. Radiother Oncol 1992; 24(1): 41–44.
4. Scherer E, Wirtz C. The role of postoperative radiotherapy in the treatment of hypernephroid
carcinoma. Strahlenther Onkol 1988; 164(7): 371–385.
5. Kao GD, Malkowicz SB, Whittington R, D’Amico AV, Wein AJ. Locally advanced renal carcinoma: low
complication rate and ecacy of postnephrectomy radiation therapy planned with CT. Radiology 1994;
193(3): 725–730.
6. Makarewicz R, Zarzycka M, Kulińska G, Windorbska W. The value of postoperative radiotherapy in
advanced renal cell cancer. Neoplasma 1998; 45(6): 380–383.
7. Kirkbride T, Cooper T. Stereotactic body radiotherapy. Guidelines for commissioners, providers and
clinicians: a national report. Clin Oncol (R Coll Radiol) 2011; 23(3): 163–164
References